{
    "id": "wrong_mix_domain_leader_00052_3",
    "rank": 35,
    "data": {
        "url": "https://www.hubrecht.eu/research-groups/clevers-group/",
        "read_more_link": "",
        "language": "en",
        "title": "Organoid group (previously Clevers Group)",
        "top_image": "https://www.hubrecht.eu/app/uploads/2018/04/Clevers_detaching-sheet-e1513608274535.jpg",
        "meta_img": "https://www.hubrecht.eu/app/uploads/2018/04/Clevers_detaching-sheet-e1513608274535.jpg",
        "images": [
            "https://www.hubrecht.eu/app/themes/hubrecht/dist/images/hubrecht-logo.svg",
            "https://www.hubrecht.eu/app/themes/hubrecht/dist/images/hubrecht-logo.svg",
            "https://www.hubrecht.eu/app/uploads/2015/08/CoverBarkeretal_RGB2-2.jpg",
            "https://www.hubrecht.eu/app/uploads/2015/08/Clevers-1-225x225.jpg",
            "https://www.hubrecht.eu/app/themes/hubrecht/dist/images/RG_square_green.png",
            "https://www.hubrecht.eu/app/themes/hubrecht/dist/images/RG_square_white.png",
            "https://www.hubrecht.eu/app/uploads/2015/08/Clevers5-150x150.jpg",
            "https://www.hubrecht.eu/app/themes/hubrecht/dist/images/placeholder-group-member.jpg",
            "https://www.hubrecht.eu/app/uploads/2015/09/Clevers_Stieneke-van-de-Brink-e1516962043608-150x150.jpg",
            "https://www.hubrecht.eu/app/uploads/2015/09/Clevers_Laura-Zeinstra-150x150.jpg",
            "https://www.hubrecht.eu/app/uploads/2015/09/Clevers_Harry-Beghtel-e1516723178804-150x150.jpg",
            "https://www.hubrecht.eu/app/uploads/2015/11/Clevers_Jeroen-Korving-1-150x150.jpg",
            "https://www.hubrecht.eu/app/themes/hubrecht/dist/images/placeholder-group-member.jpg",
            "https://www.hubrecht.eu/app/themes/hubrecht/dist/images/placeholder-group-member.jpg",
            "https://www.hubrecht.eu/app/themes/hubrecht/dist/images/placeholder-group-member.jpg",
            "https://www.hubrecht.eu/app/themes/hubrecht/dist/images/placeholder-group-member.jpg",
            "https://www.hubrecht.eu/app/uploads/2017/07/Clevers_Marie-Bannier-1-150x150.jpg",
            "https://www.hubrecht.eu/app/uploads/2017/07/Clevers_Jochem-Bernink-150x150.jpg",
            "https://www.hubrecht.eu/app/uploads/2018/12/Clevers_Amanda-Andersson-Rolf_Toestemming-150x150.jpg",
            "https://www.hubrecht.eu/app/uploads/2018/12/Geijsen_Lin-Lin_Toestemming-3-150x150.jpg",
            "https://www.hubrecht.eu/app/uploads/2018/12/Clevers_Delilah-Hendriks_Toestemming-150x150.jpg",
            "https://www.hubrecht.eu/app/uploads/2019/02/Clevers_Sangho-Lim-150x150.jpg",
            "https://www.hubrecht.eu/app/uploads/2020/12/Elena-150x150.jpg",
            "https://www.hubrecht.eu/app/uploads/2020/12/Daniel-2-150x150.png",
            "https://www.hubrecht.eu/app/uploads/2021/02/Daisong-Wang_photo-150x150.jpg",
            "https://www.hubrecht.eu/app/uploads/2022/01/HeadshotBlackAndWhite-150x150.png",
            "https://www.hubrecht.eu/app/uploads/2022/03/IMG-20211007-WA0014_1-150x150.jpg",
            "https://www.hubrecht.eu/app/uploads/2022/03/IMG-20220310-WA0024-150x150.jpg",
            "https://www.hubrecht.eu/app/uploads/2023/03/IMG_20230328_105739-150x150.jpg",
            "https://www.hubrecht.eu/app/uploads/2018/12/Clevers_Cayetano-Pleguezuelos-Manzano_Toestemming-150x150.jpg",
            "https://www.hubrecht.eu/app/uploads/2018/08/Fjodor3-150x150.jpg",
            "https://www.hubrecht.eu/app/uploads/2019/02/Clevers_Carla-Pou-Casellas-150x150.jpg",
            "https://www.hubrecht.eu/app/uploads/2019/03/Clevers_Adriana-Maritinez_student-150x150.jpg",
            "https://www.hubrecht.eu/app/uploads/2019/09/Clevers_Lulu-Huang_PhDstudent-150x150.jpg",
            "https://www.hubrecht.eu/app/uploads/2021/06/Martina_Clevers-Lab-2-pdf-146x150.jpg",
            "https://www.hubrecht.eu/app/uploads/2022/04/Hubrecht-photo-Sam-150x150.jpg",
            "https://www.hubrecht.eu/app/uploads/2023/03/Katarina-Balazova-1-150x150.jpeg",
            "https://www.hubrecht.eu/app/uploads/2023/05/Joost-Wijnakker-150x150.jpg",
            "https://www.hubrecht.eu/app/uploads/2016/08/Clevers_Carola-Ammerlaan-e1516719516712-150x150.jpg",
            "https://www.hubrecht.eu/app/themes/hubrecht/dist/images/hubrecht-logo.svg",
            "https://www.hubrecht.eu/app/themes/hubrecht/dist/images/hubrecht-logo.svg",
            "https://www.hubrecht.eu/app/themes/hubrecht/dist/images/knaw-logo.svg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": "2017-11-14T10:13:33+00:00",
        "summary": "",
        "meta_description": "",
        "meta_lang": "en",
        "meta_favicon": "/app/uploads/2015/10/cropped-favicon-hub.png",
        "meta_site_name": "Hubrecht Institute",
        "canonical_link": "https://www.hubrecht.eu/research-groups/clevers-group/",
        "text": "1985 – 1989 Postdoctoral Fellow, Cox Terhorst Lab at the Dana-Farber Cancer Institute, Boston MA, USA\n\n1989 – 1991 Assistant Professor, Department of Clinical Immunology, University of Utrecht\n\n1991 – 2002 Professor and Chairman, Dept. of Immunology, Faculty of Medicine, University of Utrecht\n\n2002 – 2012 Director Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences\n\n2002 – 2020 Professor in Molecular Genetics at University Medical Center Utrecht\n\n2002 – 2022 Principal Investigator of a research group of ~40 scientists at Hubrecht Institute, Utrecht.\n\n2022 – Guest Scientist/Advisor of Organoid research group at Hubrecht Institute, Utrecht.\n\n2012 – 2015 President of the Royal Netherlands Academy of Sciences (KNAW), Amsterdam\n\n2014 – 2020 Chief Scientific Officer of HUB Organoids Technology, Utrecht\n\n2015 – 2019 Chief Scientific Officer/Director Research of the Princess Máxima Center, Utrecht\n\n2015 – 2022 Principal Investigator at the Princess Máxima Center, Utrecht.\n\n2022 – Guest Scientist/Advisor of Organoid research group at the Princess Máxima Center, Utrecht.\n\n2017 – Oncode Investigator\n\n2020 – Professor of Molecular Genetics at University Utrecht\n\n2022 – Head of Pharma, Research and Early Development (pRED) and Member of the\n\n– Enlarged Executive Committee of F. Hoffmann-La Roche Ltd, Basel, Switzerland\n\nRead less\n\n2000 Catharijne prize for medical research\n\n2001 Award from the European Society for Clinical Investigation\n\n2001 Spinoza Award of the Netherlands Research Council (NWO)\n\n2004 Louis-Jeantet Prize for Medicine, Geneva, Switzerland\n\n2005 The Science and Society Prize, Amsterdam\n\n2005 The French honor of “Chevalier de la Legion d’Honneur”\n\n2005 Katharine Berkan Judd Award, New York\n\n2006 Rabbi Shai Shacknai Memorial Prize for Immunology and Cancer Research, Jerusalem\n\n2008 Josephine Nefkens Prize for Cancer Research (Erasmus MC, Rotterdam)\n\n2008 Meyenburg Cancer Research Award, Germany\n\n2009 The Queen Wilhelmina Dutch Cancer Society Award, Amsterdam\n\n2010 The United European Gastroenterology Federation (UEGF) Research Prize\n\n2011 The Ernst Jung Medical Award, Germany\n\n2011 Kolff prize, Amsterdam\n\n2012 Association pour la Recherche sur le Cancer (ARC) Léopold Griffuel Prize, Paris\n\n2012 William Beaumont prize of the American Gastroenterology Association\n\n2012 The Heineken Prize for Medicine\n\n2012 Knight in the Order of the Netherlands’ Lion\n\n2013 The Breakthrough Prize in Life Sciences\n\n2013 International Dream Team (with Hans Bos) by Dutch Cancer Society (KWF)\n\n2014 Massachusetts General Hospital Award in Cancer Research\n\n2014 TEFAF Oncology Chair 2014, Maastricht\n\n2014 Fellow of the AACR Academy\n\n2014 Struyvenberg European Society for Clinical Investigation (ESCI) medal\n\n2014 National Icon of the Netherlands\n\n2015 ISSCR-McEwen Award for Innovation\n\n2016 The Academy Professor Prize of the Royal Netherlands Academy\n\n2016 Kazemi Award for Research Excellence in Bio-Medicine\n\n2016 The Körber European Science Prize, Germany\n\n2016 Swammerdam medal, Amsterdam\n\n2016 The Ilse & Helmut Wachter award, Hamburg, Germany\n\n2017 Princess Takamatsu Award of Merit, Tokyo\n\n2018 Großes Verdienstkreuz mit Stern, Germany\n\n2018 Academia Europaea Erasmus Medal, Barcelona, Spain\n\n2019 Honorary Fellow of theRoyal Society of Edinburgh(UK)\n\n2019 Keio Medical Science Prize of the Keio University (Japan)\n\n2019 Citation Laureate, Web of Science Group\n\n2021 Pezcoller Foundation-AACR International Award\n\n2022 Ammodo Science Award\n\nRead less\n\n1999 Member European Molecular Biology Organisation (EMBO)\n\n2000 Member of the Royal Netherlands Academy of Sciences (KNAW)\n\n2009 Member of the Academia Europaea\n\n2012 Member of the American Academy of Arts and Sciences\n\n2012 Member of the Royal Netherlands Society of Sciences and Humanities\n\n2014 Member of the National Academy of Sciences of the USA\n\n2016 Member of the Academie des Sciences de I’Institut de France\n\n2017 Member of the Orden Pour le Mérite für Wissenschaften und Künste, Germany\n\n2019 Foreign Member of the Royal Society, London, United Kingdom\n\n2019 Honorary Fellow of the Royal Society of Edinburgh, Scotland\n\n2019 Honorary Fellowship of the Royal Society of Edinburgh, Scotland’s National Academy of Science and Letters\n\nRead less\n\n2005 – 2015 Member Scientific Advisory Board of Swiss Institute for Experimental Cancer Research, Lausanne\n\n2006 – 2008 President of the International Society of Differentiation (ISD)\n\n2007 – 2010 Member of the National Scientific Advisory Board NKI-AVL, Amsterdam\n\n2012 – 2015 Member of the Board of the American Association of Cancer Research\n\n2015 – 2021 Member of the Scientific Advisory Board of the Institute of Molecular Pathology, Vienna\n\n2016 – 2020 Member of the Scientific Advisory Board of Kallyope, New York\n\n2016 – Member of the Scientific Advisory Board of the Francis Crick Institute, London\n\n2016 – 2021 Member of the Scientific Advisory Board of Decibel Therapeutics, Boston\n\n2016 – 2022 Member of the Scientific Advisory Board of Surrozen, San Francisco\n\n2017 – 2018 President of the International Society for Stem Cell Research (ISSCR)\n\n2018 – 2021 Member of the Scientific Advisory Board of Merus, Utrecht\n\n2018 – 2022 Scientific advisor Life Science Partners, Amsterdam\n\n2019 – 2022 Non-executive member of the Board of Directors of Roche Holding Ltd, Basel\n\n2020 – 2021 Member of the Scientific Advisory Board of Volestra Therapeutic Inc., New York\n\n2020 – 2022 Chair of the Scientific Advisory Board DImed Inc., Shanghai\n\n2020 – 2022 Chair of the Scientific Advisory Board of Xilis, at Duke University (NC)\n\nRead less\n\nUnsalaried advisory positions\n\nHans Clevers is advisor/guest researcher at the Hubrecht Institute and the Princess Máxima Center for Pediatric Oncology and Oncode Investigator, all in Utrecht, NL. He also is University Professor at Utrecht University.\n\nClevers is inventor on multiple organoid patents, licensed by the KNAW to the Foundation HUB in Utrecht. He holds stock in several biotech companies based on prior Scientific Advisory Board positions, notably Xilis, Kallyope and Surrozen in the USA, and D1Med in China\n\nHe also fills rotating positions in international ‘Learned Societies’ (e.g. ISSCR, AACR), Award Juries (e.g. Francqui Prize, Brussels; Breakthrough Prize, San Francisco, WLA Prize, Shanghai) and in Scientific Advisory Boards (SABs) of the Crick Institute in London).\n\nCurrent position Since March 2022, Hans Clevers is Head of pharma Research and Early Development (pRED) of Roche, Basel Switzerland.\n\nRead less"
    }
}